Telix jumps on trial launch approval from T.G.A.

MELBOURNE: Melbourne biotech Telix Pharmaceuticals started Monday’s session up 5.3 per cent to $4.15 after

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In